Mitochondrial gene RTN4IP1 drives triple-negative breast cancer metastasis

[News]

Triple-negative breast cancer accounts for approximately 15% of all breast cancer cases. It is characterized by the absence of estrogen receptor, progesterone receptor, and HER2 expression, rendering it insensitive to conventional endocrine and targeted therapies.

More... (https://www.news-medical.net/news/20260812/Mitochondrial-gene-RTN4IP1-drives-triple-negative-breast-cancer-metastasis.aspx)